Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

March 1, 2021

Quantifying the global number of tuberculosis survivors: a modelling study.

The Lancet Infectious Diseases
Peter J DoddJames A Seddon
March 1, 2021

Tuberculosis care does not end at treatment completion- a perspective from tuberculosis survivors.

The Lancet Infectious Diseases
Ingrid Schoeman, Zolelwa Sifumba
March 1, 2021
Review

Antimicrobial drugs bearing guanidine moieties: A review.

European Journal of Medicinal Chemistry
Seong-Heun KimDaniele Castagnolo
March 1, 2021

Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Hepatology International
Harshad DevarbhaviAsia Pacific Association of Study of Liver
March 1, 2021

COVID-19 and Mycobacterium Tuberculosis Coinfection: A Case Report.

West African Journal of Medicine
A A AgadaB A Ekele
March 1, 2021

Microbiological profile in chronic granulomatous disease patients in a single Brazilian primary immunodeficiency center.

Allergologia et immunopathologia
Aimée Filippini Bifulco OliveiraMagda Maria Sales Carneiro-Sampaio
March 2, 2021

Targeting endogenous gaseous signaling molecules as novel host-directed therapies against tuberculosis infection.

Free Radical Research
Kamini GautamVikram Saini
March 2, 2021

Statin use and impact on tuberculosis risk.

Expert Review of Anti-infective Therapy
Vincent Yi-Fong SuYuh-Min Chen
March 2, 2021
Review

Understanding the gaps in elimination of tuberculosis in India.

The Indian Journal of Tuberculosis
Khushali VashiJasmin Patel
March 2, 2021
Review

Pretomanid: A novel therapeutic paradigm for treatment of drug resistant tuberculosis.

The Indian Journal of Tuberculosis
Uzma ParveenNausheen Fatima
March 2, 2021

A study of multidrug resistant tuberculosis among symptomatic household contacts of MDR-TB patients.

The Indian Journal of Tuberculosis
Benhur Joel ShadrachRishabh Goel
March 2, 2021

Risk factors for death during treatment in pulmonary tuberculosis patients in South India: A cohort study.

The Indian Journal of Tuberculosis
Jayalakshmy RamakrishnanGautam Roy
March 2, 2021
Review

Social determinants of multidrug-resistant tuberculosis: A scoping review and research gaps.

The Indian Journal of Tuberculosis
Maisam NajafizadaAtanu Sarkar
March 2, 2021

To study the impact of active case finding (ACF) among the TB patients detected in South Delhi.

The Indian Journal of Tuberculosis
Gyanendra ShuklaKhalid Umer Khayyam
March 2, 2021

Delay in diagnosis of tuberculosis and related factors from a district in Kerala, India.

The Indian Journal of Tuberculosis
N M SebastianArya S Nath
March 2, 2021

Consumption of spine by tuberculosis in the era of directly observed treatment, short-course and genomic diagnosis.

The Indian Journal of Tuberculosis
A DivyaNagarathna Siddaiah

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

© 2021 Meta ULC. All rights reserved
/feed-previews/antitubercular-agents-asm/3836da9d-42d6-47b8-b90f-bd185134b3eb